1. Home
  2. GTEC vs RVPH Comparison

GTEC vs RVPH Comparison

Compare GTEC & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

HOLD

Current Price

$0.76

Market Cap

21.9M

Sector

Industrials

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.79

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTEC
RVPH
Founded
2006
2006
Country
United States
United States
Employees
N/A
14
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
10.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTEC
RVPH
Price
$0.76
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$66.67
AVG Volume (30 Days)
115.8K
1.5M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.62
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.17
52 Week High
$2.47
$3.11

Technical Indicators

Market Signals
Indicator
GTEC
RVPH
Relative Strength Index (RSI) 50.18 43.85
Support Level $0.67 $0.32
Resistance Level $0.80 $0.86
Average True Range (ATR) 0.05 0.19
MACD 0.01 -0.12
Stochastic Oscillator 68.56 6.12

Price Performance

Historical Comparison
GTEC
RVPH

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: